6.6.13

Guías NICE mayo 2013



 
     
  1. Feverish illness in children
  2. Macular oedema (retinal vein occlusion) - ranibizumab
  3. Ovarian, fallopian tube and primary peritoneal cancer (recurrent advanced, platinum-sensitive or partially platinum-sensitive) - bevacizumab
  4. Social anxiety disorder
  5. Schizophrenia or bipolar disorder - loxapine inhalation (terminated appraisal)
  6. Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer










No hay comentarios:

Publicar un comentario